Page last updated: 2024-10-15
ed 110
Description
ED 110: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 135705573 |
MeSH ID | M0211303 |
Synonyms (10)
Synonym |
139112-73-5 |
ed 110 |
j-109384 |
5h-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6h)-dione, 12,13-dihydro-1,11-dihydroxy-12-beta-d-glucopyranosyl- |
12-beta-d-glucopyranosyl-12,13-dihydro-1,11-dihydroxy-5h-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6h)-dione |
12,13-dihydro-1,11-dihydroxy-12-beta-d-glucopyranosyl-5h-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6h)-dione |
j 109384 |
ed-110 |
1,5-anhydro-1-(7-hydroxy-1,3,10-trioxo-2,3,8,9,10,12-hexahydro-1h-indolo[2,3-a]pyrrolo[3,4-c]carbazol-9-yl)hexitol |
DTXSID90930362 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |